Table 3.

Patient Impression of Improvement and Satisfaction at 12 weeks

Impression of Improvement	Tolterodine (n = 25)	Intravaginal Estradiol (n = 24)	p-value
Change in Urinary Tract Condition
Very Much Better	3 (12%)	0 (0%)	0.44*
Much Better	8 (32%)	7 (29%)
A Little Better	8 (32%)	12 (50%)
No Change	5 (20%)	5 (21%)
A Little Worse	1 (4%)	0 (0%)
Current Urinary Tract Condition
Normal	2 (8%)	0 (0%)	0.94*
Mild	9 (36%)	11 (46%)
Moderate	10 (40%)	11 (46%)
Severe	4 (16%)	2 (8%)
Patient Satisfaction	(n = 24)	(n = 24)	p-value
Satisfaction
Completely Satisfied	5 (21%)	3 (13%)	0.39*
Somewhat Satisfied	13 (54%)	13 (54%)
Not Satisfied	6 (25%)	8 (33%)
Improvement
Much Better	4 (17%)	1 (4%)	0.86*
Better	11 (46%)	13 (54%)
About the Same	6 (25%)	9 (38%
Worse	2 (8%)	1 (4%)
Much Worse	1 (4%)	0 (0%)
Patient Perception of Improvement	(n = 23)	(n = 24)	p-value
Estimated % improvement	48.8 ± 31.7	42.1 ± 33.9	0.49
Continued Therapy	(n = 24)	(n = 23)	p-value
Comfortable to Continue: n (%) yes)	15 (63%)	18 (78%)	0.24
Change of Therapy	(n = 22)	(n = 22)	p-value
Wish another form of treatment: n (%) yes	14 (64%)	13 (41%)	0.76

^*test of trend